Balance Sheet
Cash Flow Statement
AmortizationChange in TaxesNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Cash from Financing Activities (2021 - 2025)

Historic Cash from Financing Activities for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to $14.0 million.

  • ProQR Therapeutics' Cash from Financing Activities fell 5444.11% to $14.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$31.1 million, marking a year-over-year decrease of 11910.73%. This contributed to the annual value of $76.1 million for FY2024, which is 319082.73% up from last year.
  • As of Q4 2022, ProQR Therapeutics' Cash from Financing Activities stood at $14.0 million, which was down 5444.11% from -$44.1 million recorded in Q3 2022.
  • In the past 5 years, ProQR Therapeutics' Cash from Financing Activities registered a high of $100.4 million during Q2 2021, and its lowest value of -$44.1 million during Q3 2022.